GlassScriptPhysician profile
Sakshi Kaul
NPI 1184044067
$5,358.68
in general payments reported to CMS, 2019-2025
9 companies · $2,063 in 2025
The $2,063 reported for 2025 was more than what 87% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,268 · 2021: $296 · 2022: $341 · 2023: $202 · 2024: $188 · 2025: $2,063.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,734 · Food and Beverage: $719.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,733.96 |
| Food and Beverage | $718.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,541.54 | 2019-2023 | Senza |
| Stryker Corporation | $1,035.84 | 2025 | Mild Device Kit |
| Si-Bone, INC. | $871.34 | 2025 | |
| Boston Scientific Corporation | $861.24 | 2019-2022 | |
| Abbott Laboratories | $666.20 | 2019-2025 | Eterna |
| Medtronic, INC. | $296.07 | 2024-2025 | Intellis Adaptivestim |
| Medtronic USA, INC. | $60.85 | 2019 | |
| Collegium Pharmaceutical, INC. | $13.04 | 2019 | |
| Biogen, INC. | $12.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sakshi Kaul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.